Skip to main content

U.S. Approves Health Exchanges in Four Republican-Governed States


WASHINGTON (Reuters) Jan 03 - U.S. officials on Thursday gave four states currently governed by Republicans the green light to set up their own health insurance exchanges under President Barack Obama's healthcare reform law, an initiative largely opposed by Republicans.
The U.S. Department of Health and Human Services said Idaho, Nevada, New Mexico and Utah joined a list totaling 17 states and the District of Columbia that have all won conditional approval to establish their own state exchanges, with operations set to begin on January 1, 2014.
A fifth Republican-governed state, Mississippi, applied to operate a state exchange, but has not received approval because of a dispute about how much authority state officials should exercise over the operations of its prospective online marketplace, officials said.
The U.S. administration also cleared an exchange that Arkansas plans to run in partnership with the federal government. Delaware received approval for a similar partnership exchange late last year. Both Arkansas and Delaware have Democratic governors.
Health exchanges are a central provision of Obama's Patient Protection and Affordable Care Act. The marketplaces would extend health coverage to an estimated 16 million uninsured people by allowing them to purchase private insurance at prices subsidized by federal tax credits.
In a conference call with reporters, U.S. Health and Human Services Secretary Kathleen Sebelius welcomed the advent of exchanges as "a brand new day" for U.S. healthcare that would "drive down costs" for consumers through competition.
But the plan is opposed by many Republicans, including Republican state governors, who view the healthcare law as a costly and unnecessary expansion of government bureaucracy.
The federal government is likely to end up operating exchanges in at least 32 states that have not applied to run their own. States have the choice of rejecting the exchange provision outright, or following Delaware and Arkansas by participating in federal partnership exchanges that would allow them to manage insurance plans and aid consumers.
The deadline for states to declare their intentions to run federal partnership exchanges is February 15.
Oklahoma, which rejected Obama's healthcare reforms, is asking a U.S. judge to prevent the administration from using tax credits to subsidize insurance sold in any federal exchange operating within its borders.
U.S. officials could not predict how long it might take to clarify Mississippi's status. But they said states that are unable to begin open enrollment by October can apply in November to run their own marketplaces in 2015.
"We will continue to work with (Mississippi) state officials as they determine how best to resolve these issues," Gary Cohen, the U.S. official leading the administration's exchange implementation effort, told reporters.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...

New and Generic Drug Approvals

September 5, 2012 Drug Name Active Ingredient Dosage Form/Route Sponsor Submission Type Amlodipine Besylate; Benazepril Hydrochloride amlodipine besylate; benazepril hydrochloride Capsule; Oral Aurobindo Pharma Ltd Approval Declomycin demeclocycline hydrochloride Tablet; Oral Corepharma Labeling Revision Trilipix choline fenofibrate Capsule, Delayed Release; Oral Abbott Labs Labeling Revision Trilipix choline fenofibrate Capsule, Delayed Release; Oral Abbott Labs Manufacturing Change or Addition Ziprasidone Hydrochloride ziprasidone hydrochloride Capsule; Oral Wockhardt Ltd Approval